Results 11 to 20 of about 2,645,671 (243)

Lung transplantation for patients with severe COVID-19

Science Translational Medicine, 2020
Some patients with severe COVID-19 develop end-stage pulmonary fibrosis for which lung transplantation may be the only treatment. A surgical solution for severe COVID-19 Despite optimal medical therapy, some patients with severe COVID-19 develop ...
A. Bharat, Melissa Querrey, N. Markov, Samuel Kim, C. Kurihara, R. Garza-Castillon, Adwaiy Manerikar, A. Shilatifard, R. Tomic, Y. Politanska, H. Abdala-Valencia, A. Yeldandi, J. Lomasney, A. Misharin, G. S. Budinger   +14 more
semanticscholar   +1 more source

Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis

Respiratory Research, 2020
Background Serum chitotriosidase is a promising biomarker that has shown high specificity and sensitivity in patients with sarcoidosis. The aim of this study was to investigate correlations between serum chitotriosidase, clinical phenotypes, disease ...
David Bennett, Paolo Cameli, Nicola Lanzarone, Loredana Carobene, Nicola Bianchi, Annalisa Fui, Luigi Rizzi, Laura Bergantini, Giuseppe Cillis, Miriana d’Alessandro, Maria Antonietta Mazzei, Rosa Metella Refini, Piersante Sestini, Elena Bargagli, Paola Rottoli   +14 more
doaj   +1 more source

Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis

Respiratory Research, 2020
After publication of our article [1] the authors have notified us that one of the names has been incorrectly tagged.
David Bennett, Paolo Cameli, Nicola Lanzarone, Loredana Carobene, Nicola Bianchi, Annalisa Fui, Luigi Rizzi, Laura Bergantini, Giuseppe Cillis, Miriana d’Alessandro, Maria Antonietta Mazzei, Rosa Metella Refini, Piersante Sestini, Elena Bargagli, Paola Rottoli   +14 more
doaj   +1 more source

Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter

BMC Surgery, 2022
Background Lung adenocarcinoma is the most common subtype of non-small cell lung cancer. The surgical strategy of lymph node dissection is controversial because many more patients are diagnosed at an early stage in clinical practice.
Cheng Fang, Yangwei Xiang, Weili Han
doaj   +1 more source

Developments in lung transplantation over the past decade

European Respiratory Review, 2020
With an improved median survival of 6.2 years, lung transplantation has become an increasingly acceptable treatment option for end-stage lung disease. Besides survival benefit, improvement of quality of life is achieved in the vast majority of patients ...
S. C. van der Mark, R. Hoek, M. Hellemons   +2 more
semanticscholar   +1 more source

Lung transplantation [PDF]

Clinical Medicine, 1995
The last 30 years have seen lung transplantation grow from a procedure associated with absolute failure to one which now offers excellent outcomes for patients with advanced lung disease. It has brought much needed hope and is truly a remarkable story of medical advancement in the field of respiratory medicine.
openaire   +2 more sources

Transbronchial Cryobiopsy Compared to Forceps Biopsy for Diagnosis of Acute Cellular Rejection in Lung Transplants: Analysis of 63 Consecutive Procedures

Life, 2022
Background: Acute cellular rejection (ACR) is a complication after lung transplantation (LTx). The diagnosis of ACR is based on histologic findings using transbronchial forceps biopsy (FB). However, its diagnostic accuracy is limited because of the small
Carolin Steinack, Ariana Gaspert, Fiorenza Gautschi, René Hage, Bart Vrugt, Alex Soltermann, Macé Matthew Schuurmans, Daniel Franzen   +7 more
doaj   +1 more source

Heart-lung transplantation for idiopathic pulmonary arterial hypertension and giant pulmonary artery aneurysm – case report

Journal of Cardiothoracic Surgery, 2020
Backgound Idiopathic pulmonary arterial hypertension (IPAH) is a rare condition that requires lung transplantation in patients’ refractory to medical therapy.
T. Eadington, K. Santhanakrishnan, R. Venkateswaran   +2 more
doaj   +1 more source

Case Report: Esophagectomy and Azygos Continuation of the Inferior Vena Cava: A Lethal Combination

Frontiers in Cardiovascular Medicine, 2022
Azygos continuation of the inferior vena cava (IVC) is rare in the general population and even rarer among patients with esophageal carcinoma. In 90% of cases, this congenital IVC variant is isolated and does not affect the patient’s growth or ...
Yan Zhang, Zheng Ding, Teng Mu, Xue Pan, Guoqing Zhang, Xiangnan Li   +5 more
doaj   +1 more source

Primary Erlotinib Resistance in a Patient with Non-Small Cell Lung Cancer Carrying Simultaneous Compound EGFR L718A, Q849H, and L858R Mutations

Biomolecular Concepts, 2021
Nowadays, mutations in the epidermal growth factor receptor (EGFR) kinase domain are studied in targeted therapy of non-small cell lung cancer (NSCLC) with EGFR tyrosine kinase inhibitors including gefitinib and erlotinib.
Mirtavoos-mahyari Hanifeh, Rismani Elham, Lotfabadi Alireza Sarkar, Dezfouli Azizollah Abbasi, Sheikhy Kambiz, Dezfuli Mojtaba Mokhber, Heshmatnia Jalal   +6 more
doaj   +1 more source